As a research-based family business with global presence, our client – Dr. Falk Pharma – focuses on the development and distribution of innovative medicines that improve patients' health and well-being around inflammatory bowel disease as well as digestive and metabolic problems.
The Falk Foundation e.

BM Invest GmbH, Domplatz 40, D - 48143 Münster